Clinical trial

Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction

NCT01591746

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-08-01

PhasePHASE3

Study timeline

Study start (actual)2012-08-01Date precision: month

Registry last updated2019-10-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Pain, Postoperativeunresolved

BRCA1 Mutationunresolved

BRCA2 Mutationunresolved

Breast Diseasesunresolved

Neoplasmsunresolved

Interventions

Botulinum Toxin Type ADRUG · verified · RxNorm: botulinum toxin type A

Sponsors & collaborators

Mayo Cliniclead sponsor

Allergancollaborator

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01591746 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.